A survey of over 1,000 patients with metastatic breast cancer found that 86.1% reported having experienced at least one significant treatment-related side effect, with 20.3% of those patients ending up in the hospital or emergency room and 43.2% missing at least one treatment.1 Subsequent dose reductions resulted in relief for 82.6% of patients.1 This study highlights the…
Friends of Cancer Research announced the publication of a commentary on the significance of pragmatic clinical trials in ESMO Real World Data and Digital Oncology. PCTs evaluate the effectiveness of interventions in settings that more closely resemble real-world care, aiming to produce evidence directly applicable to clinical practice. Recognizing the value that PCTs bring to oncology…
Pragmatic clinical trials (PCTs) offer a promising alternative to explanatory trials, according to a recent commentary published in the ESMO Real World Data and Digital Oncology. Such trials feature simplified study protocols and data collection methods and enable a wider patient selection pool, which the authors believe can enhance clinical research. Clinical trials with pragmatic elements can…
Underground tunnels. That is where the conversation began between Twitter/X CEO Elon Musk and former President Donald Trump before moving to reforming the US Food and Drug Administration. Musk was discussing the impact of overregulation on drilling underground tunnels to alleviate traffic in congested cities when he deftly turned to another area that he believes…
Margaret Foti, PhD, MD (hc), chief executive officer of the American Association for Cancer Research (AACR), has been selected as the recipient of the 2024 Beacon Award for Women Leaders in Oncology in recognition of her tireless and innovative leadership in the fight against cancer. The Beacon Award for Women Leaders in Oncology was established…
Retirements from the Food and Drug Administration are hardly shocking, especially in the wake of pandemic burnout. But when longtime medical device director Jeff Shuren announced his departure in July, the device world was stunned. Industry leaders, patient advocates, and FDA colleagues alike had grown accustomed to the ambitious, politically-savvy regulator. “It’s sort of hard to imagine…
Lunit, a Korean medical AI imaging company, is reportedly close to securing a major commercialization contract with a multinational pharmaceutical company for its AI biomarker platform, Lunit SCOPE. The company confirmed that these negotiations are expected to be finalized by the end of the year. According to Lunit, Lunit SCOPE’s biomarker analysis services are currently being…
What will happen to biomedical research and health care in the aftermath of the 2024 election? The differences in outcomes couldn’t be more stark. Vice President Kamala Harris, who became the Democratic frontrunner on July 21 after President Joe Biden announced his decision not to seek reelection, is expected to pursue a science agenda…
NIH Director Monica Bertagnolli and Rep. for Kentucky’s 2nd congressional district, Brett Guthrie were named recipients of Friends of Cancer Research 2024 Cancer Leadership Award. Bertagnolli and Guthrie will be honored on Sept. 19, 2024, in Washington, DC. Monica Bertagnolli will receive the Ellen V. Sigal Advocacy Leadership Award, recognizing her incredible contributions to the…
NIH Director Monica Bertagnolli and Rep. for Kentucky’s 2nd congressional district, Brett Guthrie were named recipients of Friends of Cancer Research 2024 Cancer Leadership Award. Bertagnolli and Guthrie will be honored on Sept. 19, 2024, in Washington, DC. Monica Bertagnolli will receive the Ellen V. Sigal Advocacy Leadership Award, recognizing her incredible contributions to the…
